@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/J05AF01> a ns1:ATCConcept ;
    skos:notation "J05AF01" ;
    skos:prefLabel "Zidovudin"@cs,
        "Zidovudine"@en .

<http://linked.opendata.cz/resource/ATC/J05AR01> a ns1:ATCConcept ;
    skos:notation "J05AR01" ;
    skos:prefLabel "Zidovudin a lamivudin"@cs,
        "Zidovudine and lamivudine"@en .

<http://linked.opendata.cz/resource/ATC/J05AR04> a ns1:ATCConcept ;
    skos:notation "J05AR04" ;
    skos:prefLabel "Zidovudin, lamivudin a abacavir"@cs,
        "Zidovudine, lamivudine and abacavir"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0023377> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> ;
    ns1:description "A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000103> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/COMBIVIR>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/LAMIVUDIN-ZIDOVUDIN-MYLAN-150-MG-300-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/LAMIVUDIN-ZIDOVUDIN-SANDOZ-150-MG-300-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/LAMIVUDINE-ZIDOVUDINE-TEVA-150MG-300MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RETROVIR>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/RETROVIR-250-MG>,
        <http://linked.opendata.cz/resource/sukl/medicinal-product/TRIZIVIR> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001470>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028255>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028839> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009357> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C> ;
    ns1:mayPrevent <http://linked.opendata.cz/resource/ndfrt/disease/N0000002481> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000000291> ;
    ns1:title "Zidovudin"@cs,
        "Zidovudine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001470> a ns1:PharmacologicalAction ;
    ns1:description "Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)     "@en ;
    ns1:title "Antimetabolity"@cs,
        "Antimetabolites"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028255> a ns1:PharmacologicalAction ;
    ns1:description "Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.     "@en ;
    ns1:title "Reverzní transkriptasa - inhibitory"@cs,
        "Reverse transcriptase inhibitors"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028839> a ns1:PharmacologicalAction ;
    ns1:description "Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.     "@en ;
    ns1:title "Látky proti hiv"@cs,
        "Anti-hiv agents"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000291> a ns1:DiseaseOrFinding ;
    ns1:description "An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.     "@en ;
    ns1:title "Aids"@cs,
        "Acquired immunodeficiency syndrome"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002481> a ns1:DiseaseOrFinding ;
    ns1:description "The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.     "@en ;
    ns1:title "Těhotenství - komplikace infekční"@cs,
        "Pregnancy complications, infectious"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000103> a ns1:MechanismOfAction ;
    ns1:title "Reverse Transcriptase Inhibitors"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009357> a ns1:PhysiologicEffect ;
    ns1:title "Increased Immunologically Active Molecule Activity"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/COMBIVIR> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AR01> ;
    ns1:title "COMBIVIR"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/LAMIVUDIN-ZIDOVUDIN-MYLAN-150-MG-300-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AR01> ;
    ns1:title "LAMIVUDIN/ZIDOVUDIN MYLAN 150 MG/300 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/LAMIVUDIN-ZIDOVUDIN-SANDOZ-150-MG-300-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AR01> ;
    ns1:title "LAMIVUDIN/ZIDOVUDIN SANDOZ 150 MG/300 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/LAMIVUDINE-ZIDOVUDINE-TEVA-150MG-300MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AR01> ;
    ns1:title "LAMIVUDINE/ZIDOVUDINE TEVA 150MG/300MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RETROVIR> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AF01> ;
    ns1:title "RETROVIR"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/RETROVIR-250-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AF01> ;
    ns1:title "RETROVIR 250 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/TRIZIVIR> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/J05AR04> ;
    ns1:title "TRIZIVIR"@cs .


